Epidemiology of glial and non-glial brain tumours in Europe

European Journal of Cancer

Volumn 48, Issue 10, 2012, Pages 1532-1542

  Crocetti, Emanuele ^a   Trama, Annalisa ^b   Stiller, Charles ^c   Caldarella, Adele ^a   Soffietti, Riccardo ^d   Jaal, Jana ^e   Weber, Damien C ^f   Ricardi, Umberto ^g   Slowinski, J ^h   Brandes, Alba ^i,az   Zielonk, N ^j   Van Eycken, E ^k   Sundseth, H ^l   Marreaud, S ^m   Audisio, R ⁿ   Hedelin, G ^o   Launoy, G ^p   Guizard, A V ^q   Bouvier, A M ^r   Woronoff, A S ^s   Buemi, A ^t   Tretarre, B ^u   Colonna, M ^v   Bara, S ^w   Ganry, O ^x   Grosclaude, P ^y   Holleczek, B ^z   Geissler, J ^aa   Tryggvadottir, L ^ab   Comber, H ^ac   Bellu F ^ad   Ferretti, S ^ae   Serraino, D ^af   Vercelli, M ^ag   Vitarelli, S ^ah   Federico, M ^ai   Fusco, M ^aj   Traina, A ^ak   Michiara, M ^al   Giacomin, A ^am   Tumino, R ^an   Mangone, L ^ao   Falcini, F ^ap   Iannelli, A ^aq   Budroni, M ^ar   Piffer, S ^as   Intrieri, T ^at   La Rosa, F ^au   Contiero, P ^av   Zambon, P ^aw   Casali, P G ^b   Gatta, G ^b   Gronchi, A ^b   Licitra, L ^b   Ruzza, M ^b   Sowe, S ^b   Capocaccia, R ^ax   De Angelis, R ^ax   Mallone, S ^ax   Tavilla, A ^ax   Dei Tos, A P ^ay   England, K ^ba   Ursin, G ^bb   Visser, O ^bc   Otter, R ^bc   Siesling, S ^bc   van der Zwan, J M ^bc   Coebergh, J W W ^bd   Schouten, H ^be   Rachtan, J ^bf   Gozdz, S ^bg   Zwierko, M ^bh   Bielska Lasota, M ^bi   Miranda, A ^bj   Safaei Diba, Ch ^bk   Primic Zakelj, M ^bl   Mateos, A ^bm   Izarzugaza, I ^bn   Torrella Ramos, A ^bo   Marcos Gragera, R ^bp   Sanchez M J ^bq   Navarro, C ^br,bs   Ardanaz, Eva ^bt   Galceran, J ^bu   Martinez Garcia, C ^bv   Melchor, J M ^bv   Adolfsson, J ^bw   Lambe, M ^bx   Moller T R ^by   Ringborg, U ^bz   Jundt, G ^ca   Usel, M ^cb   Ess, S M ^cc   Bordoni, A ^cd   Konzelmann, I ^ce   Lutz, J M ^cf   Greenberg, D C ^cg   Wilkinson, J ^ch   Roche, M ^ci   Verne, J ^cj   Meechan, D ^ck   Lawrence, G ^cl   Coleman, M P ^cm   Mackay, J ^cn   Gavin, A ^co   Brewster, D H ^cp   Kunkler, I ^cq   Steward, J ^cr   more..

^a ISPO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Battista Hospital ^*  (Italy)

^e TARTU UNIVERSITY HOSPITAL   (Estonia)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY OF TURIN   (Italy)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ BELLARIA HOSPITAL   (Italy)

^j Austrian National Cancer Registry   (Austria)

^k Belgian Cancer Registry   (Belgium)

^l The European Cancer Patients Coalition   (Belgium)

^m EORTC DATA CENTER   (Belgium)

ⁿ European Society of Surgical Oncology   (Belgium)

^o Cancer Registry of Bas Rhin   (France)

^p Calvados Digestive Cancer Registry   (France)

^q Calvados General Cancer Registry   (France)

^r ote d'Or Digestive Cancer Registry   (France)

^s Doubs Cancer Registry   (France)

^t Haut Rhin Cancer Registry   (France)

^u Herault Cancer Registry   (France)

^v Isere's Cancer Registry   (France)

^w Manche Cancer Registry   (France)

^x Somme Cancer Registry   (France)

^y Tarn Cancer Registry   (France)

^z SAARLAND CANCER REGISTRY   (Germany)

^aa CML Advocates Network   (Germany)

^ab ICELANDIC CANCER REGISTRY   (Iceland)

^ac National Cancer Registry of Ireland   (Ireland)

^ad Alto Adige Cancer Registry   (Italy)

^ae Ferrara Cancer Registry   (Italy)

^af Friuli Venezia Giulia Cancer Registry   (Italy)

^ag UNIVERSITY OF GENOA   (Italy)

^ah Macerata Province Cancer Registry   (Italy)

^ai MODENA CANCER REGISTRY   (Italy)

^aj Napoli Cancer Registry   (Italy)

^ak Palermo Breast Cancer Registry   (Italy)

^al PARMA CANCER REGISTRY   (Italy)

^am Center for Epidemiology and Prevention in Oncology   (Italy)

^an CIVILE M P AREZZO HOSPITAL   (Italy)

^ao S MARIA NUOVA HOSPITAL   (Italy)

^ap Romagna Cancer Registry   (Italy)

^aq Salerno Cancer Registry   (Italy)

^ar Sassari Cancer Registry   (Italy)

^as Osservatorio Epidemiologico   (Italy)

^at Tuscan Cancer Registry   (Italy)

^au Umbria Cancer Registry   (Italy)

^av Varese Cancer Registry   (Italy)

^aw Veneto Cancer Registry   (Italy)

^ax ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^ay Local Health Unit No 9 Region of Veneto   (Italy)

^az Local Health Unit   (Italy)

^ba Malta National Cancer Registry   (Malta)

^bb CANCER REGISTRY OF NORWAY   (Norway)

^bc Department of Cancer Registry and Research   (Netherlands)

^bd Eindhoven Cancer Registry   (Netherlands)

^be MAASTRICHT UNIVERSITY   (Netherlands)

^bf Cracow Cancer Registry   (Poland)

^bg Kielce Cancer Registry   (Netherlands)

^bh INSTITUTE OF ONCOLOGY   (Poland)

^bi NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^bj Southern Portugal Cancer Registry   (Portugal)

^bk National Cancer Registry of   (Slovakia)

^bl INSTITUTE OF ONCOLOGY   (Slovenia)

^bm Albacete Cancer Registry   (Spain)

^bn Departamento de Sanidad Gobierno Vasco   (Spain)

^bo Castillon Cancer Registry   (Spain)

^bp CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^bq Granada Cancer Registry   (Spain)

^br Murcia Regional Health Authority   (Spain)

^bs CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^bt Navarra Cancer Registry   (Spain)

^bu Tarragona Cancer Registry   (Spain)

^bv ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^bw Regional Cancer Center Stockholm and Gotland   (Sweden)

^bx Regional Cancer Center Uppsala Orebro   (Sweden)

^by LUND UNIVERSITY HOSPITAL   (Sweden)

^bz KAROLINSKA INSTITUTE   (Sweden)

^ca Cancer Registry of Basel   (Switzerland)

^cb GENEVA CANCER REGISTRY   (Switzerland)

^cc St Gallen Cancer Registry   (Switzerland)

^cd Ticino Cancer Registry   (Switzerland)

^ce Valais Cancer Registry   (Switzerland)

^cf National Institute for Cancer Epidemiology and Registration   (Switzerland)

^cg Eastern Cancer Registration and Information Centre   (United Kingdom)

^ch Northern and Yorkshire Cancer Registry   (United Kingdom)

^ci UNIVERSITY OF OXFORD   (United Kingdom)

^cj South West Public Health Observatory   (United Kingdom)

^ck Trent Cancer Registry   (United Kingdom)

^cl Northwest Cancer Intelligence Service   (United Kingdom)

^cm LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^cn UNIVERSITY COLLEGE LONDON   (United Kingdom)

^co Northern Ireland Cancer Registry   (United Kingdom)

^cp Scottish Cancer Registry   (United Kingdom)

^cq UNIVERSITY OF EDINBURGH   (United Kingdom)

^cr Welsh Cancer Intelligence Surveillance Unit   (United Kingdom)

more..

Author keywords

Central nervous system; Epidemiology; Estimates; Glial tumours; Incidence; Non glial brain tumours; Prevalence; Rare cancer; Survival

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOROID PLEXUS TUMOR; EMBRYONAL CARCINOMA; EPENDYMOMA; EUROPE; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PREVALENCE; PRIORITY JOURNAL;

EID: 84862016066     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.12.013     Document Type: Article

References (31)

1. M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M.S. Berger Epidemiology of primary brain tumors: current concepts and review of the literature Neuro Oncol 4 2002 278 299
2. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr.
3. P. Kaatsch Epidemiology of childhood cancer Cancer Treat Rev 36 2010 277 285
4. M. Sant, C. Allemanni, and M. Santaquilani EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary Eur J Cancer 45 2009 931 991
5. Sant M, Minicozzi P, Lagorio S, et al. Survival of European patients with central nervous system tumours. Int J Cancer 2011; doi: 10.1002/ijc.26335. [Epub ahead of print].
6. G. Gatta, G. Zigon, and R. Capocaccia Survival of European children and young adults with cancer diagnosed 1995-2002 Eur J Cancer 45 2009 992 1005
7. World Health Organization. International Classification of Diseases. 10th revision, Geneva; 1992.
8. Percy C, Shanmugaratnam K, Whelan S, et al. International Classification of Diseases for Oncology (ICD-O), 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
9. J.M. Kros, T. Gorlia, and M.C. Kouwenhoven Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome J Neuropathol Exp Neurol 66 2007 545 551
10. D.N. Louis, H. Ohgaki, and O.D. Wiestler The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
11. R. Capocaccia, M. Colonna, and I. Corazziari Measuring cancer prevalence in Europe: the EUROPREVAL Project Ann Oncol 13 2002 831 839
12. R. Capocaccia, and R. De Angelis Estimating the completeness of prevalence based on cancer registry data Stat Med 16 1997 425 440
13. H. Brenner, B. Söderman, and T. Hakulinen Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancers patients in Finland Int J Epidemiol 31 2002 456 462
14. S. Francisci, R. Capocaccia, and E. Grande The cure of cancer: a European perspective Eur J Cancer 45 2009 1067 1079
15. J.A. Schwartzbaum, J.L. Fisher, K.D. Aldape, and M. Wrensch Epidemiology and molecular pathology of glioma Nat Clin Pract Neurol 2 2006 494 503
16. Altekruse SF, Kosary CL, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2007, Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
17. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global Cancer Statistics, 2002. CA Cancer J Clin 55 2005 74 108
18. Z. Morris, W.N. Whiteley, and W.T. Longstreth Jr Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis BMJ 339 2009 b3016
19. A. Ahlbom, M. Feychting, and A. Green Standing committee on epidemiology. epidemiologic evidence on mobile phones and tumor risk. A review Epidemiology 20 2009 639 652
20. INTERPHONE Study Group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study.Int J Epidemiol 2010;39:675-94.
21. V.G. Khurana, C. Teo, M. Kundi, L. Hardell, and M. Carlberg Cell phones and brain tumors: a review including the long-term epidemiologic data Surgical Neurol 72 2009 205 215
22. IARC. IARC monograph on the evaluation of carcinogenic risks to humans. In: Non-Ionizing radiation, radiofrequency electromagnetic fields, vol. 102. Lyon: International Agency for Research on cancer, in press.
23. R. Baana, Y. Grosse, and B. Lauby-Secretan Carcinogenicity of radiofrequency electromagnetic fields The Lancet Oncol 12 2011 624 626 [published Online: 22 June 2011]
24. Dammers R, Schouten JW, Haitsma IK, et al. Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre. Acta Neurochir. doi: 10.1007/s00701-010-0752-0.
25. S. Hoffman, J.M. Propp, and B.J. McCarthy Temporal trends in incidence of primary brain tumors in the United States, 1985-1991 Neuro-Oncol 8 2006 27 37
26. A. Micheli, R. Ciampichini, and W. Oberaigner The advantage of women in cancer survival: An analysis of EUROCARE-4 data Eur J Cancer 45 2009 1017 1027
27. S.M. Bentzen, G. Heeren, and B. Cottier Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project Radiother Oncol 75 2005 355 365
28. H. Brem, and S. Piantadosi Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345 1995 1008 1012
29. W.P. Mason, R.D. Maestro, and D. Eisenstat Canadian recommendations for the treatment of glioblastoma multiforme Curr Oncol 14 2007 110 117
30. K.R. Porter, B.J. McCarthy, S. Freels, Y. Kim, and F.G. Davis Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology Neuro Oncol 12 2010 520 527
31. European Parliament and Council of the European Communities (1999). Decision No 1295/1999/EC of the European Parliament and of the Council of 29 April 1999 adopting a programme of Community action on rare diseases within the framework for action in the field of public health (1999 to 2003).